EX039
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EX039, covering 2025-02-26 to 2025-02-26. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Oral EX039 in Subjects with Mild Alzheimer's Disease [Phase 2]